NEWS

eviti, Inc. (formerly known as ITA Partners) will showcase its innovative business model, facilitating and aligning high-quality cancer care delivery with appropriate payment, at the first Care Innovations Summit in Washington, DC on January 26th, 2012. The event, hosted by the Center for Medicare & Medicaid Innovation, Office of the ...

Philadelphia, PA (January 18, 2012) - eviti, Inc. (formerly known as ITA Partners, Inc.) announced today that it has deployed eviti® | Clinical Trials as an enhancement to its oncology decision-support platform. Physicians using the eviti solution now have access to information on thousands of federally registered cancer clinical trials ...

ITA Partners, Inc. announced that it has officially changed its company name to eviti, Inc. The new name reflects the company's transformation to a health information technology business delivering web-based decision-support services to improve the quality of cancer care and reduce cost - beyond oncology pathways. eviti is the culmination ...

ITA Partners (ITA) announced today that Maryland Physicians Care (MPC) will use ITA's proprietary oncology decision-support platform - eviti - to improve oncology care and manage costs for its patients. MPC physicians will use the web-based platform to improve adherence to evidence-based care for cancer patients and to obtain preauthorization for ...

"Oncology risk management requires attention to detail, great sensitivity when talking to patients, respect from their doctors, tremendous oncology expertise, and access to leading experts. Further, it demands an advanced, yet easy-to-use infrastructure to support and facilitate all of those functions. ITA Partners excels in all of these areas. It ...

"When ITA gets involved, it's like a new family comes into your life. No matter why I called, our ITA nurse always helped. She got information for us ... She made sure I understood everything, and if I didn't understand, she'd review it with me and help me figure out ...

Philadelphia, PA - April 14, 2011 - DAKOTACARE, a South Dakota managed care organization, owned by the South Dakota State Medical Association and focused on keeping patient care decisions in the hands of physicians, has contracted to implement ITA Partners' proprietary web-based oncology decision-support platform - eviti - across its ...

Philadelphia, PA - April 13, 2011 - The Florida Comprehensive Care Network (FCCN) and ITA Partners, Inc. (ITA), have signed a long term strategic agreement under which FCCN will use eviti, ITA's oncology decision-support platform, across its network of oncologists. ITA is an independent, third-party expert with nearly a decade ...

Americans treated, over-treated until death The Associated Press offers a look at how American medicine includes ongoing treatment - without real discussions of options - even as patients face imminent death.  Rosaria Vandenberg went home to share a final, touching moment with her 2-year-old daughter one day before dying of an ...

"I was skeptical. A company that would support me, helping me attain best-possible care, yet linked to me through my insurer? Well, I can tell you - it IS true. ITA gets treatments approved quickly. They run interference. When I need medication, they work to secure it at a good ...

"ITA provides meaningful continuity of care. Even in the best treatment situations, care can be fragmented across hospitals, doctors' offices and patients' homes. ITA bridges the gaps, collaboratively and professionally. When patients and families are distressed, ITA spends time with them. ITA helps them understand diagnoses and treatment, while focusing ...

Philadelphia, PA - March 9, 2011 - To improve outcomes and manage costs for members with cancer, ADVANTAGE Health Solutions, Inc. (ADVANTAGE) has contracted with ITA Partners (ITA) to implement eviti - ITA's proprietary oncology decision-support platform - across their provider network. ITA is an independent, third-party expert with nearly ...

Philadelphia, PA - January 12, 2011 - ITA Partners, Inc., an independent, third-party expert with nearly a decade of experience supporting oncology treatment decisions and patient care, today announced that it has signed an agreement with TML Intergovernmental Employee Benefit Pool (TML) to implement its proprietary eviti system to ensure ...

Philadelphia, PA, December 15, 2010 - ITA Partners, Inc., an independent, third-party expert with nearly a decade of experience supporting oncology treatment decisions and patient care, today announced that it has signed an agreement with Health Plan Select to implement its proprietary eviti solution to streamline system-wide processes for the ...

Philadelphia, PA, December 9, 2010 - ITA Partners, Inc., an independent, third-party expert with nearly a decade of experience in transforming the quality of oncology care, today announced that Government Employees Health Association (GEHA) has chosen eviti - ITA's proprietary oncology decision-support platform - to ensure prompt authorization of care ...

ONCOLOGY & BIOTECH NEWS - November 2010 Issue   OP-ED By Eduardo Beruff  Nowhere today is there a greater need for a unified solution to improve access to care, patient outcomes, and cost-efficiency than in cancer care. Comprising hundreds of different diseases with thousands of therapeutic choices, cancer seems to defy a simple ...

DOTMED - November 2010 Issue   by Olga Deshchenko, DOTmed News Reporter This report originally appeared in the November 2010 issue of DOTmed Business News  As one of the world's deadliest killers, cancer remains the medical community's arch enemy. While new guidelines and research continues to help doctors battle the disease, these tools also ...

ITA Partners receives URAC Health Utilitation Management Accreditation Philadelphia, PA, September 28, 2010 - ITA Partners, Inc. announced today that it has been awarded Health Utilization Management Accreditation from URAC, a Washington DC-based health care accrediting organization that establishes quality standards for the health care industry. URAC's Health Utilization Management Accreditation ...

Philadelphia, PA, April 26, 2010 - Arlene Forastiere, MD, SVP of Medical Affairs at ITA Partners, and an internationally recognized expert in the treatment of cancers of the head, neck, larynx and esophagus, and professor at Johns Hopkins University School of Medicine, has accepted an invitation to participate on the ...

DRUG TOPICS - January 2011 Issue   Oncology treatment and benefits are changing. Buy-and-bill, the traditional methodology that had physicians buying chemotherapeutic products, treating in the office, and billing the payer, is going the way of surgery by barbers. But no one is quite sure what will replace the one-time standard of ...